Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Basic Sciences

Evidence for Prostanoid Biosynthesis as a Biochemical Feature of Certain Subclasses of Non-Small Cell Carcinomas of the Lung as Determined in Established Cell Lines Derived from Human Lung Tumors

Walter C. Hubbard, Michael C. Alley, Glenn N. Gray, Karen C. Green, Theodore L. McLemore and Michael R. Boyd
Walter C. Hubbard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael C. Alley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glenn N. Gray
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen C. Green
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theodore L. McLemore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael R. Boyd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published February 1989
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Detectable levels (≥0.2 pmol/106 cells) of one or more prostanoid species resultant to calcium ionophore A23187-induced biosynthesis from endogenous arachidonic acid were distributed in 28 cell lines derived from different histological classes of lung tumors as follows: large cell undifferentiated carcinoma (3 of 3 cell lines); adenosquamous carcinoma (1 of 2 cell lines); squamous cell carcinoma (0 of 2 cell lines); adenocarcinoma (9 of 10 cell lines); bronchioloalveolar cell carcinoma (2 of 2 cell lines); and small cell carcinoma (1 of 9 cell lines). Using the mean levels of 9α,11β-prostaglandin F2, prostaglandin F2α, prostaglandin D2, prostaglandin E2, thromboxane B2 and 6-keto-prostaglandin F1α as an index of prostaglandin H (PGH) synthase activity, the distribution in cell lines representative of the different histological classes of human lung tumors exhibiting PGH synthase activity exceeding mean values ≥2 pmol/106 cells was as follows: large cell undifferentiated carcinoma (3 of 3 cell lines), adenosquamous carcinoma (1 of 2 cell lines), adenocarcinoma (8 of 10) cell lines), bronchioloalveolar cell carcinoma (2 of 2 cell lines) and small cell carcinoma (0 of 9 cell lines). Three different prostanoid species accumulated to mean levels ≥2 pmol/106 cells. Prostaglandin E2 levels exceeded 2 pmol/106 cells in 14 of the 16 cell lines in which this prostanoid accumulated to detectable levels. Cumulative levels of prostaglandin F2α exceeded 2 pmol/106 cells in 9 of the 15 cell lines in which prostaglandin F2α reached detectable levels. Detectable levels of thromboxane B2 were observed in five cell lines with thromboxane B2 accumulation exceeding 2 pmol/106 cells in two of the five cell lines. 9α,11β-prostaglandin F2 and 6-keto-prostaglandin F1α accumulated to detectable levels in the culture medium of one cell line, while prostaglandin D2 accumulation to detectable levels was observed in two cell lines. Stimulation of cultured human lung tumor cells exhibiting PGH synthase activity ≥2 pmol/106 cells in the presence of 10-5 m exogenous arachidonic acid resulted in a 2- to 4- fold increase in the accumulation of individual prostanoids, while the inclusion of a 10-5 m exogenous concentration of arachidonic acid failed to stimulate detectable prostanoid production in human lung tumor cells in which PGH synthase activity was not previously expressed. The predominance of PGH synthase activity in cell lines derived from human non-small cell carcinomas of the lung suggest that prostanoid biosynthesis may be characteristic of tumor cells comprising certain histological subclasses of human non-small cell carcinomas of the lung, particularly adenocarcinoma, bronchioloalveolar cell carcinoma, large cell undifferentiated carcinoma, and possibly adenosquamous carcinoma.

Footnotes

  • ↵1 This project has been funded at least in part with Federal funds from the Department of Health and Human Services under Contract N01-CO-74102. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government.

  • ↵2 To whom requests for reprints should be addressed, at the Program Development Research Group, Building 560, Room 32-60, Frederick, MD 21701-1013.

  • Received July 25, 1988.
  • Revision received October 6, 1988.
  • Accepted November 10, 1988.
  • ©1989 American Association for Cancer Research.
PreviousNext
Back to top
February 1989
Volume 49, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evidence for Prostanoid Biosynthesis as a Biochemical Feature of Certain Subclasses of Non-Small Cell Carcinomas of the Lung as Determined in Established Cell Lines Derived from Human Lung Tumors
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Evidence for Prostanoid Biosynthesis as a Biochemical Feature of Certain Subclasses of Non-Small Cell Carcinomas of the Lung as Determined in Established Cell Lines Derived from Human Lung Tumors
Walter C. Hubbard, Michael C. Alley, Glenn N. Gray, Karen C. Green, Theodore L. McLemore and Michael R. Boyd
Cancer Res February 15 1989 (49) (4) 826-832;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evidence for Prostanoid Biosynthesis as a Biochemical Feature of Certain Subclasses of Non-Small Cell Carcinomas of the Lung as Determined in Established Cell Lines Derived from Human Lung Tumors
Walter C. Hubbard, Michael C. Alley, Glenn N. Gray, Karen C. Green, Theodore L. McLemore and Michael R. Boyd
Cancer Res February 15 1989 (49) (4) 826-832;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Basic Sciences

  • Glucocorticoid Insensitivity of P1798 Lymphoma Cells Is Associated with Production of a Factor That Attenuates the Lytic Response
  • Forestomach and Kidney Carcinogenicity of Caffeic Acid in F344 Rats and C57BL/6N × C3H/HeN F1 Mice
  • Immunohistochemical and Pharmacokinetic Characterization of Site-specific Immunoconjugate 15A8-Glycyl-tyrosyl-(N-ε-diethylenetriamine Pentaacetic Acid)-lysine Derived from Anti-Breast Carcinoma Monoclonal Antibody 15A8
Show more Basic Sciences

Articles

  • Glucocorticoid Insensitivity of P1798 Lymphoma Cells Is Associated with Production of a Factor That Attenuates the Lytic Response
  • Forestomach and Kidney Carcinogenicity of Caffeic Acid in F344 Rats and C57BL/6N × C3H/HeN F1 Mice
  • Immunohistochemical and Pharmacokinetic Characterization of Site-specific Immunoconjugate 15A8-Glycyl-tyrosyl-(N-ε-diethylenetriamine Pentaacetic Acid)-lysine Derived from Anti-Breast Carcinoma Monoclonal Antibody 15A8
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement